-
1
-
-
26644471951
-
Drug resistance by evasion of antiangiogenic targeting of VEGF signalling in late-stage pancreatic islet tumors
-
Casanovas O., Hicklin D.J., Bergers G., Hanahan D. Drug resistance by evasion of antiangiogenic targeting of VEGF signalling in late-stage pancreatic islet tumors. Cancer Cell 2005, 8:299-309.
-
(2005)
Cancer Cell
, vol.8
, pp. 299-309
-
-
Casanovas, O.1
Hicklin, D.J.2
Bergers, G.3
Hanahan, D.4
-
2
-
-
32944479256
-
Assessing global invasion of newly diagnosed glial tumors with whole-brain proton MR spectroscopy
-
Cohen B.A., Knopp E.A., Rusinek H., Babb J.S., Zagzag D., Gomen O. Assessing global invasion of newly diagnosed glial tumors with whole-brain proton MR spectroscopy. Am. J. Neuroradiol. 2005, 26:2170-2177.
-
(2005)
Am. J. Neuroradiol.
, vol.26
, pp. 2170-2177
-
-
Cohen, B.A.1
Knopp, E.A.2
Rusinek, H.3
Babb, J.S.4
Zagzag, D.5
Gomen, O.6
-
3
-
-
0035839236
-
Abolished angiogenicity and tumorigenicity of rat glioma by 1-naphthalenemonosulfate
-
Cuevas P., Carceller F., Diaz D., Reimers D., Fernández M., Lozano R.M., González-Corrochano R., Giménez-Gallego G. Abolished angiogenicity and tumorigenicity of rat glioma by 1-naphthalenemonosulfate. Neurosci. Lett. 2001, 30:185-188.
-
(2001)
Neurosci. Lett.
, vol.30
, pp. 185-188
-
-
Cuevas, P.1
Carceller, F.2
Diaz, D.3
Reimers, D.4
Fernández, M.5
Lozano, R.M.6
González-Corrochano, R.7
Giménez-Gallego, G.8
-
4
-
-
25444530122
-
Dihidroxy-2,5-benzene-sulfonate (dobesilate) elicits growth arrest and apoptosis in glioma cells
-
Cuevas P., Diaz-González D., Dujovny M. Dihidroxy-2,5-benzene-sulfonate (dobesilate) elicits growth arrest and apoptosis in glioma cells. Neurol. Res. 2005, 27:797-800.
-
(2005)
Neurol. Res.
, vol.27
, pp. 797-800
-
-
Cuevas, P.1
Diaz-González, D.2
Dujovny, M.3
-
6
-
-
0027530832
-
Effects of EGF, bFGF, NGF and PDGF (bb) on cell proliferative, migratory and invasive capacities of human brain-tumors biopsies in vitro
-
Engenbroaten O., Bjerkvig R., Pedersen P.H., Laerun O.D. Effects of EGF, bFGF, NGF and PDGF (bb) on cell proliferative, migratory and invasive capacities of human brain-tumors biopsies in vitro. Int. J. Cancer 1993, 53:209-214.
-
(1993)
Int. J. Cancer
, vol.53
, pp. 209-214
-
-
Engenbroaten, O.1
Bjerkvig, R.2
Pedersen, P.H.3
Laerun, O.D.4
-
7
-
-
77951226293
-
Gentisic acid, a compound associated with plant defense and a metabolite of aspirin, heads a new class of in vivo FGF inhibitor
-
Fernández I.S., Cuevas P., Angulo J., López-Navajas P., Canales-Mayordomo A., Lozano R.M., Valverde S., Jiménez-Barbero J., Romero A., Giménez-Gallego G. Gentisic acid, a compound associated with plant defense and a metabolite of aspirin, heads a new class of in vivo FGF inhibitor. J. Biol. Chem. 2010, 285:11714-11729.
-
(2010)
J. Biol. Chem.
, vol.285
, pp. 11714-11729
-
-
Fernández, I.S.1
Cuevas, P.2
Angulo, J.3
López-Navajas, P.4
Canales-Mayordomo, A.5
Lozano, R.M.6
Valverde, S.7
Jiménez-Barbero, J.8
Romero, A.9
Giménez-Gallego, G.10
-
8
-
-
85000275965
-
CALDIRET study group, effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRECT study): randomised, double-blind, placebo-controlled, multicentre trial
-
Haritoglou C., Gerss J., Sauerland C., Kampik A., Ulbig M.W. CALDIRET study group, effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRECT study): randomised, double-blind, placebo-controlled, multicentre trial. Lancet 2009, 373:1316-1318.
-
(2009)
Lancet
, vol.373
, pp. 1316-1318
-
-
Haritoglou, C.1
Gerss, J.2
Sauerland, C.3
Kampik, A.4
Ulbig, M.W.5
-
9
-
-
2542561964
-
Bevacizumab plus irinotecan, fluorouracil and leucovorin for metastatic colorectal cancer
-
Hurwitz H., Fehrenbacher L., Novotny W., Cartwright T., Hainsworth J., Heim W., Berlin J., Baron A., Griffing S., Holmgren E., Ferrara N., Fyfe G., Rogers B., Ross R., Kabbinavar F. Bevacizumab plus irinotecan, fluorouracil and leucovorin for metastatic colorectal cancer. N. Engl. J. Med. 2004, 350:2335-2342.
-
(2004)
N. Engl. J. Med.
, vol.350
, pp. 2335-2342
-
-
Hurwitz, H.1
Fehrenbacher, L.2
Novotny, W.3
Cartwright, T.4
Hainsworth, J.5
Heim, W.6
Berlin, J.7
Baron, A.8
Griffing, S.9
Holmgren, E.10
Ferrara, N.11
Fyfe, G.12
Rogers, B.13
Ross, R.14
Kabbinavar, F.15
-
10
-
-
0030767269
-
Cell release of bioactive fibroblast growth factor 2 by exon 6-encoded sequence of vascular endothelial growth factor
-
Jonca F., Ortega N., Gleizes P.E., Bertrand N., Plouet J. Cell release of bioactive fibroblast growth factor 2 by exon 6-encoded sequence of vascular endothelial growth factor. J. Biol. Chem. 1997, 272:24203-24209.
-
(1997)
J. Biol. Chem.
, vol.272
, pp. 24203-24209
-
-
Jonca, F.1
Ortega, N.2
Gleizes, P.E.3
Bertrand, N.4
Plouet, J.5
-
11
-
-
0026715782
-
Effects of growth factors on a human glioma cell line during invasion into rat brain aggregates in culture
-
Lund-Johansen M., Forsberg K., Bjerkvig R., Laerum O.D. Effects of growth factors on a human glioma cell line during invasion into rat brain aggregates in culture. Acta Neuropathol. 1992, 84:190-197.
-
(1992)
Acta Neuropathol.
, vol.84
, pp. 190-197
-
-
Lund-Johansen, M.1
Forsberg, K.2
Bjerkvig, R.3
Laerum, O.D.4
-
12
-
-
55849130720
-
Novel anti-angiogenic therapies for malignant gliomas
-
Norden A.D., Drappatz J., Wen P.Y. Novel anti-angiogenic therapies for malignant gliomas. Lancet Neurol. 2008, 7:1152-1160.
-
(2008)
Lancet Neurol.
, vol.7
, pp. 1152-1160
-
-
Norden, A.D.1
Drappatz, J.2
Wen, P.Y.3
-
13
-
-
0024848666
-
C6 glioma cells produce basic fibroblast growth factor that can stimulate their own proliferation
-
Okumura N., Takimoto K., Okada M., Nakagawa H.J. C6 glioma cells produce basic fibroblast growth factor that can stimulate their own proliferation. Biochemistry 1989, 106:904-909.
-
(1989)
Biochemistry
, vol.106
, pp. 904-909
-
-
Okumura, N.1
Takimoto, K.2
Okada, M.3
Nakagawa, H.J.4
-
14
-
-
60649106195
-
Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis
-
Paez-Ribes M., Allen E., Hudock J., Takeda T., Okuyama H., Vinals F., Inoue M., Bergers G., Hanahan D., Casanovas O. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 2009, 15:220-231.
-
(2009)
Cancer Cell
, vol.15
, pp. 220-231
-
-
Paez-Ribes, M.1
Allen, E.2
Hudock, J.3
Takeda, T.4
Okuyama, H.5
Vinals, F.6
Inoue, M.7
Bergers, G.8
Hanahan, D.9
Casanovas, O.10
-
15
-
-
12944272151
-
Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs
-
Song S., Wientjes M.G., Gan Y., Au J.L.S. Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:8658-8663.
-
(2000)
Proc. Natl. Acad. Sci. U.S.A.
, vol.97
, pp. 8658-8663
-
-
Song, S.1
Wientjes, M.G.2
Gan, Y.3
Au, J.L.S.4
-
16
-
-
0032601052
-
Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Register in the United States, 1990-1994
-
Surawicz T.S., McCarthy B.J., Kupelian V., Jukich P.J., Brunner J.M., Davis F.G. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Register in the United States, 1990-1994. Neuro Oncol. 1999, 1:14-25.
-
(1999)
Neuro Oncol.
, vol.1
, pp. 14-25
-
-
Surawicz, T.S.1
McCarthy, B.J.2
Kupelian, V.3
Jukich, P.J.4
Brunner, J.M.5
Davis, F.G.6
-
17
-
-
77952809712
-
Effects of bevacizumab plus irinotecan on response and survival in patients with recurrent malignant glioma: a systemic review and survival-gain analyses
-
Xu T., Chen J., Lu Y., Wolff J.E.A. Effects of bevacizumab plus irinotecan on response and survival in patients with recurrent malignant glioma: a systemic review and survival-gain analyses. BMC Cancer 2010, 10:252. 10.1186/1471-2407.
-
(2010)
BMC Cancer
, vol.10
, pp. 252
-
-
Xu, T.1
Chen, J.2
Lu, Y.3
Wolff, J.E.A.4
-
18
-
-
0034761804
-
Nontoxic doses of suramin enhance activity of Doxorubicin in prostate tumors
-
Zhang Y., Song S., Yang F., Au J.L.S., Wientjes M.G. Nontoxic doses of suramin enhance activity of Doxorubicin in prostate tumors. J. Pharmacol. Exp. Ther. 2001, 299:426-433.
-
(2001)
J. Pharmacol. Exp. Ther.
, vol.299
, pp. 426-433
-
-
Zhang, Y.1
Song, S.2
Yang, F.3
Au, J.L.S.4
Wientjes, M.G.5
|